| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.955 | 2.848 | 3.963 | 2.987 | 0 | 1.500 | 502 | 0 | 310 |
| Total Income - EUR | - | 2.955 | 2.848 | 3.963 | 2.987 | 0 | 1.500 | 502 | 0 | 310 |
| Total Expenses - EUR | - | 524 | 535 | 556 | 486 | 478 | 1.178 | 536 | 544 | 651 |
| Gross Profit/Loss - EUR | - | 2.431 | 2.312 | 3.407 | 2.500 | -478 | 322 | -34 | -544 | -342 |
| Net Profit/Loss - EUR | - | 2.342 | 2.227 | 3.288 | 2.411 | -478 | 278 | -49 | -544 | -342 |
| Employees | - | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
Check the financial reports for the company - Doctobus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 2.832 | 2.822 | 3.647 | 3.554 | 2.503 | 1.502 | 1.028 | 379 | 128 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 319 | 775 | 342 | 294 | 0 | 4 | 4 | 0 | 0 |
| Cash | - | 2.513 | 2.047 | 3.305 | 3.259 | 2.503 | 1.498 | 1.024 | 379 | 128 |
| Shareholders Funds | - | 2.387 | 2.739 | 3.340 | 2.461 | 1.936 | 327 | 278 | -266 | -606 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 511 | 83 | 306 | 1.092 | 567 | 1.175 | 750 | 794 | 734 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
6399
|
|||||||||
Comments - Doctobus Srl